Get started
Author

Azwidihwi Takalani

Observed names: A. Takalani, Azwi Takalani, Azwidhwi Takalani, Azwidihwi N Takalani
ORCID: 0000-0001-5136-4208
Observed ORCID: 0000-0001-5136-4208
OpenAlex ID: A5000617054
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study
2022 · Linda-Gail Bekker, Nigel Garrett, et al. · The Lancet · 89
PDF
Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa
2022 · Ameena Goga, Linda-Gail Bekker, et al. · The Lancet · 69
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trial
2024 · Glenda E Gray, Kathryn Mngadi, et al. · The Lancet Infectious Diseases · 54
Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study
2021 · Simbarashe Takuva, Azwidhwi Takalani, et al. · New England Journal of Medicine · 50
PDF
Vaccine effectiveness against hospital admission in South African health care workers who received a homologous booster of Ad26.COV2 during an Omicron COVID19 wave: Preliminary Results of the Sisonke 2 Study
2021 · Glenda E Gray, Shirley Collie, et al. · medRxiv · 41
PDF
Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial
2022 · Simbarashe Takuva, Azwidhwi Takalani, et al. · PLoS Medicine · 23
Post-COVID symptom profiles and duration in a global convalescent COVID-19 observational cohort: Correlations with demographics, medical history, acute COVID-19 severity and global region
2023 · Shelly Karuna, Jorge A Gallardo-Cartagena, et al. · Journal of Global Health · 19
PDF
Vaccine pharmacovigilance in South Africa: successes and limitations of current approaches
2024 · J. Peter, A. Takalani, et al. · Expert Opinion on Drug Safety · 9
Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study
2025 · Nigel Garrett, Asa Tapley, et al. · EClinicalMedicine · 8
Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial
2025 · Kelly E Seaton, Carmen A Paez, et al. · The Lancet HIV · 6
Safety, effectiveness and immunogenicity of heterologous mRNA-1273 boost after prime with Ad26.COV2.S among healthcare workers in South Africa: The single-arm, open-label, phase 3 SHERPA study
2024 · Nigel Garrett, Tarylee Reddy, et al. · PLOS Global Public Health · 6
Allergic reactions to the Ad26.COV2.S vaccine in South Africa
2021 · Jonny Peter, Cascia Day, et al. · Journal of Allergy and Clinical Immunology Global · 6
PDF
Vascular thrombosis after single dose Ad26.COV2.S vaccine in healthcare workers in South Africa: open label, single arm, phase 3B study (Sisonke study)
2023 · Barry Frank Jacobson, Elise Schapkaitz, et al. · BMJ Medicine · 5
PDF
Analytical treatment interruption among women with HIV in southern Africa who received VRC01 or placebo in the Antibody Mediated Prevention Study: ATI stakeholder engagement, implementation and early clinical data
2025 · Shelly Karuna, Fatima Laher, et al. · Journal of the International AIDS Society · 4
PDF
Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV
2025 · Nonhlanhla N. Mkhize, Bo Zhang, et al. · Nature Communications · 3
PDF
Africa is an Essential Partner in the Research and Development of an HIV Vaccine
2025 · Glenda Gray, Carolyn Williamson, et al. · Current HIV Research · 2
Pregnancy and contraceptive use among participants of childbearing potential in the HVTN 705 HIV vaccine trial in Southern Africa
2025 · Pamela Mda, Kathryn Mngadi, et al. · Frontiers in Reproductive Health · 2
PDF
Safety of a second homologous Ad26.COV2.S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa
2024 · Azwidihwi Takalani, Michelle Robinson, et al. · Vaccine · 2
PDF
Investigation of a suspected tuberculosis outbreak in a long-term care facility, KwaZulu-Natal, South Africa, July-October 2013
2014 · C. Mugero, C. Atchison, et al. · International Journal of Infectious Diseases
PDF
Works count: 19
Citation count: 398
H-index: 8
I10-index: 7
Year
Topic
Type